Concentra Group Holdings Parent, Inc.

NYSE•CON

CEO: Mr. William Keith Newton

セクター: Healthcare

業種: Medical - Equipment & Services

上場日: 2010-05-25

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

連絡先情報

4714 Gettysburg Road, PO Box 2034, Mechanicsburg, PA, 17055, United States

717-972-1100

www.concentra.com

時価総額

$2.93B

PER (TTM)

17.4

53.9

配当利回り

1.1%

52週高値

$24.69

52週安値

$18.55

52週レンジ

69%

順位41Top 44.9%

4.0

F-Score

改良版 Piotroski 分析

4年ファンダメンタル

堅調 • 4 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2022-2025

財務ダッシュボード

Q4 2025 データ

売上高

$539.10M-100.00%

直近4四半期の推移

EPS

$0.27+70.59%

直近4四半期の推移

フリーCF

$180.86M+0.00%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Revenue Growth Driven by Acquisitions Revenue reached $2.16B USD, marking a strong 13.9% increase year-over-year, driven by acquisitions completed in 2025.

Major Acquisitions Integrated Completed Nova ($265.0M) and Pivot Onsite ($54.4M) acquisitions, significantly boosting overall patient visit volume across segments.

EBITDA Margin Improvement Adjusted EBITDA margin improved to 20.0% due to increased volume and staffing efficiencies realized across occupational health centers.

Strong Liquidity Position Repurchased $22.4M common stock; Revolving Credit Facility balance zeroed out following $85M voluntary repayment by year-end.

リスク要因

Labor Cost and Shortage Risks Labor shortages, increased turnover, and union activity could cause significant operating cost increases and reduce overall profitability.

Regulatory and Compliance Burden Conducting business in a heavily regulated industry faces risks from new interpretations, sanctions, and increased compliance costs.

Reimbursement Rate Constraints State fee schedules and cost containment initiatives may constrain ability to match cost inflation with necessary reimbursement rate increases.

Cybersecurity Breach Exposure Failure of IT systems via cyber-attack may compromise confidential patient data, resulting in potential legal and reputational harm.

見通し

Focus on Organic Growth Strategy Strategy focuses on driving organic growth via market share capture and expanding through adjacent, mission-aligned acquisitions.

Expanding Service Offerings Continually evaluating expansion of onsite health clinics and telemedicine behavioral health services to meet evolving customer demand.

Debt Structure Management Term Loan balance of $931.2M remains, with derivative contracts hedging variable interest rate exposure through February 2028.

Share Repurchase Authorization $80.0M remains authorized for common stock repurchases under the program set to expire on December 31, 2027.

同業比較

売上高 (TTM)

BHC

$10.31B

+7.1%

OGN

$6.22B

-2.9%

XRAY

$3.68B

-3.0%

粗利益率 (最新四半期)

BEAM

95.0%

-471.3pp

CPRX

90.8%

-2.1pp

NTLA

73.9%

-572.8pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
ITGR	$2.97B	28.7	6.0%	41.0%
CON	$2.93B	17.4	46.6%	69.2%
PBH	$2.92B	15.6	10.2%	30.9%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

2.5%

緩やかな成長

4四半期純利益CAGR

-3.8%

収益性の安定

キャッシュフロー安定性

100%

優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年5月5日

EPS:-

売上高:-

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし